Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D04WUA
|
|||
Former ID |
DNC000469
|
|||
Drug Name |
CP-101,606
|
|||
Synonyms |
SCHEMBL5888841; CHEMBL321758; AKOS030627610; CP-101581; (1R,2R)-1-(4-Hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol; 1-((1R,2R)-Rel-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl)-4-phenylpiperidin-4-ol
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Parkinson disease [ICD-11: 8A00.0; ICD-9: 332] | Phase 2 | [1] | |
Ischemic stroke [ICD-11: 8B11.5Z; ICD-9: 434.91] | Investigative | [2] | ||
Therapeutic Class |
Analgesics
|
|||
Structure |
Download2D MOL |
|||
Formula |
C20H25NO3
|
|||
Canonical SMILES |
CC(C(C1=CC=C(C=C1)O)O)N2CCC(CC2)(C3=CC=CC=C3)O
|
|||
InChI |
1S/C20H25NO3/c1-15(19(23)16-7-9-18(22)10-8-16)21-13-11-20(24,12-14-21)17-5-3-2-4-6-17/h2-10,15,19,22-24H,11-14H2,1H3/t15-,19+/m0/s1
|
|||
InChIKey |
QEMSVZNTSXPFJA-HNAYVOBHSA-N
|
|||
CAS Number |
CAS 134234-12-1
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT00073476) A Study to Evaluate the Efficacy and Safety of CP-101,606 in Subjects With an Acute Stroke. U.S. National Institutes of Health. | |||
REF 2 | Current status of neuroprotective agents in the treatment of acute ischemic stroke. Curr Neurol Neurosci Rep. 2001 Jan;1(1):13-8. | |||
REF 3 | NMDA receptors as targets for drug action in neuropathic pain. Eur J Pharmacol. 2001 Oct 19;429(1-3):71-8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.